Advanced Bio-Technologies, Inc. ("ABT") is a privately held biopharmaceutical company based in Suwanee, Georgia, and is part of the Health Edge Investment Partners portfolio of companies.

ABT specializes in the treatment of scars and markets a range of unique patent protected products based on cross-linking  technology under the brand Kelo-cote^® and physician only bioCorneum.^®+

ABT has direct operations in the US. Kelo-cote^® products are also marketed in many countries throughout the world via a network of local marketing partners.

ABT's mission is to become a Global leader in the scar treatment market with a focus on quality throughout the organization to ensure the marketing and development of effective products that set the standard of care.

ABT's dedication to quality is demonstrated through a strong clinical program that provides clinical evidence of efficacy to support our products, and establishes ABT as a serious medical company.

http://advancedbiotech.com